VectoLex and VectoBac Products for Mosquito-Control

Sarasota County is pursuing a sole source procurement for VectoLex and VectoBac mosquito control products through Solicitation Number 2024-ISS-262, specifically targeting the county's Mosquito Management division. The procurement will be with ADAPCO, LLC as the exclusive distributor of products manufactured by Valent BioSciences, LLC, with the primary objective of supporting the county's Integrated Pest Management Plan. The products are specialized mosquito control solutions designed to reduce mosquito-borne disease risks, with unique capabilities to treat woodland and swamp areas without requiring citizen evacuation. The solicitation was released on July 2, 2024, with key deadlines including July 9, 2024, for submitting questions and July 10, 2024, at 5:00 pm for final responses, which must be submitted electronically through the ProcureNow portal. Evaluation will focus on vendors' ability to provide equivalent products, with Sarasota County reserving the right to cancel the sole source procurement if alternative vendors can demonstrate comparable product capabilities.

The procurement is subject to various regulatory requirements, including employment eligibility verification and tax exemption rules. Potential vendors must comply with cybersecurity mandates, implementing appropriate administrative, technical, and physical controls for business and information technology systems. The contract is structured for a three-year period from October 9, 2024, to October 8, 2027, with an estimated annual expenditure increasing from $80,000 to $120,000 per fiscal year. The county emphasizes that while Valent BioSciences is the sole manufacturer, vendors believing they can provide equivalent goods must complete an Intent to Sole Source Response form with supporting documentation. The procurement is contingent upon the availability of lawfully budgeted funds, and Sarasota County retains the right to terminate the purchase order with appropriate notice. The specific VectoLex products have demonstrated a 7.5% active ingredient success rate in local mosquito populations, offering a strategic rotation of pesticide use to mitigate potential mosquito resistance.